QNRX - Quoin Pharmaceuticals Ltd
8.43
-0.240 -2.847%
Share volume: 12,387
Last Updated: 03-09-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$8.67
-0.24
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 03-13-2025 | 05-13-2025 | 08-07-2025 | 11-06-2025 | |
| Assets | ||||||||
| Total Assets | 16.123 M | 14.055 M | 11.389 M | 15.709 M | 12.955 M | 8.913 M | 6.424 M | |
| Current Assets | 15.265 M | 13.221 M | 10.497 M | 14.926 M | 12.497 M | 8.479 M | 6.015 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 12.856 M | 9.725 M | 7.190 M | 10.434 M | 7.731 M | 6.122 M | 3.582 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.834 M | 2.845 M | 3.117 M | 3.623 M | 3.822 M | 1.668 M | 1.831 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 858.334 K | 833.334 K | 891.724 K | 783.334 K | 458.334 K | 433.334 K | 408.334 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 16.123 M | 14.055 M | 11.389 M | 15.709 M | 12.955 M | 8.913 M | 6.424 M | |
| Total liabilities | 6.998 M | 6.576 M | 5.947 M | 6.505 M | 7.029 M | 6.361 M | 7.638 M | |
| Total current liabilities | 4.224 M | 3.953 M | 3.474 M | 4.181 M | 4.856 M | 4.337 M | 5.765 M | |
| Accounts Payable | 358.510 K | 819.674 K | 222.636 K | 905.704 K | 644.057 K | 873.684 K | 1.861 M | |
| Other liabilities | 2.774 M | 2.624 M | 2.474 M | 2.324 M | 2.174 M | 2.024 M | 1.874 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 2.774 M | 2.624 M | 2.474 M | 2.324 M | 2.174 M | 2.024 M | 1.874 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 9.126 M | 7.478 M | 5.442 M | 9.205 M | 5.926 M | 2.551 M | -1.215 M | |
| Common stock | 57.656 M | 57.983 M | 58.296 M | 64.370 M | 64.904 M | 65.225 M | 65.407 M | |
| Retained earnings | -48.531 M | -50.505 M | -52.855 M | -55.166 M | -58.978 M | -62.674 M | -66.622 M |